Envivo Bio, founded in San Carlos, California, is dedicated to advancing the understanding of the human gastrointestinal microbiome through innovative technology. The company's core mission is to provide comprehensive, non-invasive sampling solutions that enable detailed analysis of microbiome and metabolome profiles from all regions of the gastrointestinal tract. Their flagship product, CapScan®, is designed to collect these samples efficiently, offering new insights into gut health and its impact on overall well-being. Envivo Bio primarily targets the biotech and healthcare markets, aiming to support research and clinical diagnostics.

Notable achievements for Envivo Bio include a Phase SBIR Grant awarded by the National Science Foundation, underscoring their innovative approach and potential impact. The company has also been featured in prominent studies published in journals like Nature and Nature Metabolism, highlighting the unique capabilities of CapScan® in profiling dietary and lipid compounds in the gut. These accomplishments reflect Envivo Bio's significant contributions to microbiome research and its growing influence in the biotech industry.